Impact of IL-17 on cells of the monocyte lineage in health and disease

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 9, Issue 2, 2009, Pages 178-186

  Sergejeva, Svetlana ^a   Linden A ^b  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antigen presenting cell; APC; Cytokine; Dendritic cell; Inflammation; Interleukin; Macrophage; Osteoclast

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL ACTIVITY; CELL LINEAGE; CYTOKINE PRODUCTION; EFFECTOR CELL; ENTERITIS; GRAFT REJECTION; HEMATOPOIESIS; HISTIOCYTOSIS X; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; MONOCYTE; MYOCARDITIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; ASTHMA; CELL LINEAGE; GRAFT REJECTION; HUMANS; INTERLEUKIN-17; MONOCYTES; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 67650290823     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153009788452444     Document Type: Review

References (93)

1. Doherty, T.M. (1995) T-cell regulation of macrophage function. Curr. Opin. Immunol., 7(3), 400-404.
2. Kolls, J.K. and Linden, A. (2004) Interleukin-17 family members and inflammation. Immunity, 21(4), 467-476.
3. Rouvier, E.; Luciani, M.F.; Mattei, M.G.; Denizot, F. and Golstein, P. (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol., 150(12), 5445-5456.
4. Ivanov, S. and Linden, A. (2009) IL-17 as a drug target in human disease. Trends Pharmacol. Sci., 30(2), 95-103.
5. Yao, Z.; Painter, S.L.; Fanslow, W.C.; Ulrich, D.; Macduff, B.M.; Spriggs, M.K. and Armitage, R.J. (1995) Human IL-17: a novel cytokine derived from T cells. J. Immunol., 155(12), 5483-5486.
6. Afanasyeva, M.; Georgakopoulos, D.; Belardi, D.F.; Ramsundar, A.C.; Barin, J.G.; Kass, D.A. and Rose, N.R. (2004) Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am. J. Pathol., 164(3), 807-815.
7. Jovanovic, D.V.; Di Battista, J.A.; Martel-Pelletier, J.; Jolicoeur, F.C.; He, Y.; Zhang, M.; Mineau, F. and Pelletier, J.P. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol., 160(7), 3513-3521.
8. Antonysamy, M.A.; Fanslow, W.C.; Fu, F.; Li, W.; Qian, S.; Troutt, A.B. and Thomson, A.W. (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol., 162(1), 577-584.
9. Valaperti, A.; Marty, R.R.; Kania, G.; Germano, D.; Mauermann, N.; Dirnhofer, S.; Leimenstoll, B.; Blyszczuk, P.; Dong, C.; Mueller, C.; Hunziker, L. and Eriksson, U. (2008) CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol., 180(4), 2686-2695.
10. Steinman, L. (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med., 13(2), 139-145.
11. Park, H.; Li, Z.; Yang, X.O.; Chang, S.H.; Nurieva, R.; Wang, Y.H.; Wang, Y.; Hood, L.; Zhu, Z.; Tian, Q. and Dong, C. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol., 6(11), 1133-1141.
12. Harrington, L.E.; Hatton, R.D.; Mangan, P.R.; Turner, H.; Murphy, T.L.; Murphy, K.M. and Weaver, C.T. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol., 6(11), 1123-1132.
13. Lenarczyk, A.; Helsloot, J.; Farmer, K.; Peters, L.; Sturgess, A. and Kirkham, B. (2000) Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin. Exp. Immunol., 122(1), 41-48.
14. Shin, H.C.; Benbernou, N.; Esnault, S. and Guenounou, M. (1999) Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine, 11(4), 257-266.
15. Teunissen, M.B.; Koomen, C.W.; de Waal Malefyt, R.; Wierenga, E.A. and Bos, J.D. (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol., 111(4), 645-649.
16. Albanesi, C.; Scarponi, C.; Cavani, A.; Federici, M.; Nasorri, F. and Girolomoni, G. (2000) Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol., 115(1), 81-87.
17. Molet, S.; Hamid, Q.; Davoine, F.; Nutku, E.; Taha, R.; Page, N.; Olivenstein, R.; Elias, J. and Chakir, J. (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol., 108(3), 430-438.
18. Ferretti, S.; Bonneau, O.; Dubois, G.R.; Jones, C.E. and Trifilieff, A. (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol., 170(4), 2106-2112.
19. Pongcharoen, S.; Somran, J.; Sritippayawan, S.; Niumsup, P.; Chanchan, P.; Butkhamchot, P.; Tatiwat, P.; Kunngurn, S. and Searle, R.F. (2007) Interleukin-17 expression in the human placenta. Placenta, 28(1), 59-63.
20. Coury, F.; Annels, N.; Rivollier, A.; Olsson, S.; Santoro, A.; Speziani, C.; Azocar, O.; Flacher, M.; Djebali, S.; Tebib, J.; Brytting, M.; Egeler, R.M.; Rabourdin-Combe, C.; Henter, J.I.; Arico, M. and Delprat, C. (2008) Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med., 14(1), 81-87.
21. Song, C.; Luo, L.; Lei, Z.; Li, B.; Liang, Z.; Liu, G.; Li, D.; Zhang, G.; Huang, B. and Feng, Z.H. (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J. Immunol., 181(9), 6117-6124.
22. Zhou, Q.; Desta, T.; Fenton, M.; Graves, D.T. and Amar, S. (2005) Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun., 73(2), 935-943.
23. Starnes, T.; Robertson, M.J.; Sledge, G.; Kelich, S.; Nakshatri, H.; Broxmeyer, H.E. and Hromas, R. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol., 167(8), 4137-4140.
24. Kang, C.M.; Jang, A.S.; Ahn, M.H.; Shin, J.A.; Kim, J.H.; Choi, Y.S.; Rhim, T.Y. and Park, C.S. (2005) Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am. J. Respir. Cell Mol. Biol., 33(3), 290-296.
25. Yao, Z.; Fanslow, W.C.; Seldin, M.F.; Rousseau, A.M.; Painter, S.L.; Comeau, M.R.; Cohen, J.I. and Spriggs, M.K. (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity, 3(6), 811-821.
26. Honorati, M.C.; Meliconi, R.; Pulsatelli, L.; Cane, S.; Frizziero, L. and Facchini, A. (2001) High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford), 40(5), 522-527.
27. Yao, Z.; Spriggs, M.K.; Derry, J.M.; Strockbine, L.; Park, L.S.; VandenBos, T.; Zappone, J.D.; Painter, S.L. and Armitage, R.J. (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine, 9(11), 794-800.
28. Linden, A. (2007) A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling. Sci. STKE., 2007(398), re4.
29. Gratchev, A.; Kzhyshkowska, J.; Duperrier, K.; Utikal, J.; Velten, F.W. and Goerdt, S. (2004) The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells. Scand. J. Immunol., 60(3), 233-237.
30. Ihle, J.N. (1996) STATs: signal transducers and activators of transcription. Cell, 84(3), 331-334.
31. Bruder, J.T. and Kovesdi, I. (1997) Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol., 71(1), 398-404.
32. Subramaniam, S.V.; Cooper, R.S. and Adunyah, S.E. (1999) Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem. Biophys. Res. Commun., 262(1), 14-19.
33. Subramaniam, S.V.; Pearson, L.L. and Adunyah, S.E. (1999) Interleukin-17 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937. Biochem. Biophys. Res. Commun., 259(1), 172-177.
34. Faour, W.H.; Mancini, A.; He, Q.W. and Di Battista, J.A. (2003) T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J. Biol. Chem., 278(29), 26897-26907.
35. Faour, W.H.; Alaaeddine, N.; Mancini, A.; He, Q.W.; Jovanovic, D. and Di Battista, J.A. (2005) Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor-alpha gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts. J. Biol. Chem., 280(10), 9536-9546.
36. Beklen, A.; Ainola, M.; Hukkanen, M.; Gurgan, C.; Sorsa, T. and Konttinen, Y.T. (2007) MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J. Dent. Res., 2007, 86(4), 347-351.
37. Di Battista, J.A.; Martel-Pelletier, J. and Pelletier, J. (1999) Suppression of tumor necrosis factor (TNF-alpha) gene expression by prostaglandin E(2). Role of early growth response protein-1 (Egr-1). Osteoarthritis Cartilage, 7(4), 395-398.
38. Stamp, L.K.; James, M.J. and Cleland, L.G. (2004) Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma. J. Rheumatol., 31(7), 1255-1264.
39. Jovanovic, D.V.; Di Battista, J.A.; Martel-Pelletier, J.; Reboul, P.; He, Y.; Jolicoeur, F.C. and Pelletier, J.P. (2001) Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages. J. Rheumatol., 28(4), 712-718.
40. Li, H.; Chen, J.; Huang, A.; Stinson, J.; Heldens, S.; Foster, J.; Dowd, P.; Gurney, A.L. and Wood, W.I. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA, 97(2), 773-778.
41. Broxmeyer, H.E. (1996) Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? J. Exp. Med., 183(6), 2411-2415.
42. Schwarzenberger, P.; Huang, W.; Oliver, P.; Byrne, P.; La Russa, V.; Zhang, Z. and Kolls, J.K. (2001) Il-17 mobilizes peripheral blood stem cells with short- and long-term repopulating ability in mice. J. Immunol., 167(4), 2081-2086.
43. Schwarzenberger, P.; La Russa, V.; Miller, A.; Ye, P.; Huang, W.; Zieske, A.; Nelson, S.; Bagby, G.J.; Stoltz, D.; Mynatt, R.L.; Spriggs, M. and Kolls, J.K. (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol., 161(11), 6383-6389.
44. Starnes, T.; Broxmeyer, H.E.; Robertson, M.J. and Hromas, R. (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol., 169(2), 642-646.
45. Wu, Q.; Martin, R.J.; Rino, J.G.; Breed, R.; Torres, R.M. and Chu, H.W. (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes. Infect., 9(1), 78-86.
46. Ye, P.; Rodriguez, F.H.; Kanaly, S.; Stocking, K.L.; Schurr, J.; Schwarzenberger, P.; Oliver, P.; Huang, W.; Zhang, P.; Zhang, J.; Shellito, J.E.; Bagby, G.J.; Nelson, S.; Charrier, K.; Peschon, J.J. and Kolls, J.K. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med., 194(4), 519-527.
47. Huang, W.; Na, L.; Fidel, P.L. and Schwarzenberger, P. (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis., 190(3), 624-631.
48. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol., 3(1), 23-35.
49. Muller, U.; Stenzel, W.; Kohler, G.; Werner, C.; Polte, T.; Hansen, G.; Schutze, N.; Straubinger, R.K.; Blessing, M.; McKenzie, A.N.; Brombacher, F. and Alber, G. (2007) IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol., 179(8), 5367-5377.
50. Rutitzky, L.I.; Bazzone, L.; Shainheit, M.G.; Joyce-Shaikh, B.; Cua, D.J. and Stadecker, M.J. (2008) IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J. Immunol., 180(4), 2486-2495.
51. Higgins, S.C.; Jarnicki, A.G.; Lavelle, E.C. and Mills, K.H. (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol., 177(11), 7980-7989.
52. Fitzpatrick, A.M.; Holguin, F.; Teague and W.G.Brown, L.A. (2008) Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J. Allergy Clin. Immunol., 121(6), 1372-1378.
53. Benfield, T.; Lange, P. and Vestbo, J. (2008) COPD stage and risk of hospitalization for infectious disease. Chest, 134(1), 46-53.
54. Harrison, F. (2007) Microbial ecology of the cystic fibrosis lung. Microbiology, 153(Pt 4), 917-923.
55. Loong, C.C.; Hsieh, H.G.; Lui, W.Y.; Chen, A. and Lin, C.Y. (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J. Pathol., 197(3), 322-332.
56. Hsieh, H.G.; Loong, C.C.; Lui, W.Y.; Chen, A. and Lin, C.Y. (2001) IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transplant. Int., 14(5), 287-298.
57. Tang, J.L.; Subbotin, V.M.; Antonysamy, M.A.; Troutt, A.B.; Rao, A.S. and Thomson, A.W. (2001) Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation, 72(2), 348-350.
58. Li, J.; Simeoni, E.; Fleury, S.; Dudler, J.; Fiorini, E.; Kappenberger, L.; von Segesser, L.K. and Vassalli, G. (2006) Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur. J. Cardiothorac. Surg., 29(5), 779-783.
59. Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
60. Burke, C.M.; Theodore, J.; Dawkins, K.D.; Yousem, S.A.; Blank, N.; Billingham, M.E.; Van Kessel, A.; Jamieson, S.W.; Oyer, P.E.; Baldwin, J.C. (1984) Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest, 86(6), 824-829.
61. Sumpter, T.L. and Wilkes, D.S. (2004) Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am. J. Physiol. Lung. Cell Mol. Physiol., 286(6), L1129-1139.
62. Burlingham, W.J.; Love, R.B.; Jankowska-Gan, E.; Haynes, L.D.; Xu, Q.; Bobadilla, J.L.; Meyer, K.C.; Hayney, M.S.; Braun, R.K.; Greenspan, D.S.; Gopalakrishnan, B.; Cai, J.; Brand, D.D.; Yoshida, S.; Cummings, O.W. and Wilkes, D.S. (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J. Clin. Invest., 117(11), 3498-3506.
63. Sonderegger, I.; Rohn, T.A.; Kurrer, M.O.; Iezzi, G.; Zou, Y.; Kastelein, R.A.; Bachmann, M.F. and Kopf, M. (2006) Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol., 36(11), 2849-2856.
64. Rangachari, M.; Mauermann, N.; Marty, R.R.; Dirnhofer, S.; Kurrer, M.O.; Komnenovic, V.; Penninger, J.M. and Eriksson, U. (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med., 203(8), 2009-2019.
65. Langrish, C.L.; Chen, Y.; Blumenschein, W.M.; Mattson, J.; Basham, B.; Sedgwick, J.D.; McClanahan, T.; Kastelein, R.A. and Cua, D.J. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 201(2), 233-240.
66. Mizoguchi, A. and Mizoguchi, E. (2008) Inflammatory bowel disease, past, present and future: lessons from animal models. J. Gastroenterol., 43(1), 1-17.
67. Nielsen, O.H.; Kirman, I.; Rudiger, N.; Hendel, J. and Vainer, B. (2003) Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol., 38(2), 180-185.
68. Fujino, S.; Andoh, A.; Bamba, S.; Ogawa, A.; Hata, K.; Araki, Y.; Bamba, T. and Fujiyama, Y. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 52(1), 65-70.
69. Ogawa, A.; Andoh, A.; Araki, Y.; Bamba, T. and Fujiyama, Y. (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol., 110(1), 55-62.
70. Yang, N.; Isbel, N.M.; Nikolic-Paterson, D.J.; Li, Y.; Ye, R.; Atkins, R.C. and Lan, H.Y. (1998) Local macrophage proliferation in human glomerulonephritis. Kidney Int., 54(1), 143-151.
71. Matsumoto, K. and Kanmatsuse, K. (2003) Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy. Scand. J. Urol. Nephrol., 37(2), 164-171.
72. Stamp, L.K.; James, M.J. and Cleland, L.G. (2004) Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol. Cell Biol., 82(1), 1-9.
73. Kotake, S.; Udagawa, N.; Takahashi, N.; Matsuzaki, K.; Itoh, K.; Ishiyama, S.; Saito, S.; Inoue, K.; Kamatani, N.; Gillespie, M.T.; Martin, T.J. and Suda, T. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest., 103(9), 1345-1352.
74. Chabaud, M.; Durand, J.M.; Buchs, N.; Fossiez, F.; Page, G.; Frappart, L. and Miossec, P. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum., 42(5), 963-970.
75. Ziolkowska, M.; Koc, A.; Luszczykiewicz, G.; Ksiezopolska-Pietrzak, K.; Klimczak, E.; Chwalinska-Sadowska, H. and Maslinski, W. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol., 164(5), 2832-2838.
76. Koenders, M.I.; Kolls, J.K.; Oppers-Walgreen, B.; van den Bersselaar, L.; Joosten, L.A.; Schurr, J.R.; Schwarzenberger, P.; van den Berg, W.B. and Lubberts, E. (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum., 52(10), 3239-3247.
77. Udagawa, N.; Takahashi, N.; Akatsu, T.; Tanaka, H.; Sasaki, T.; Nishihara, T.; Koga, T.; Martin, T.J. and Suda, T. (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA, 87(18), 7260-7264.
78. Teitelbaum, S.L. (2000) Bone resorption by osteoclasts. Science, 289(5484), 1504-1508.
79. Arend, W.P. and Dayer, J.M. (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum., 38(2), 151-160.
80. Badolato, R. and Oppenheim, J.J. (1996) Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin. Arthritis Rheum., 26(2), 526-538.
81. Portanova, J.P.; Zhang, Y.; Anderson, G.D.; Hauser, S.D.; Masferrer, J.L.; Seibert, K.; Gregory, S.A. and Isakson, P.C. (1996) Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., 184(3), 883-891.
82. Caughey, G.E.; Pouliot, M.; Cleland, L.G. and James, M.J. (1997) Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J. Immunol., 158(1), 351-358.
83. Woessner, J.F.Jr. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5(8), 2145-2154.
84. Beverley, P.C.; Egeler, R.M.; Arceci, R.J. and Pritchard, J. (2005) The Nikolas Symposia and histiocytosis. Nat. Rev. Cancer, 5(6), 488-494.
85. Poston, R.N.; Chanez, P.; Lacoste, J.Y.; Litchfield, T.; Lee, T.H. and Bousquet, J. (1992) Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am. Rev. Respir. Dis., 145(4 Pt 1), 918-921.
86. Liu, M.C.; Hubbard, W.C.; Proud, D.; Stealey, B.A.; Galli, S.J.; Kagey-Sobotka, A.; Bleecker, E.R. and Lichtenstein, L.M. (1991) Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am. Rev. Respir. Dis., 144(1), 51-58.
87. Letuve, S.; Lajoie-Kadoch, S.; Audusseau, S.; Rothenberg, M.E.; Fiset, P.O.; Ludwig, M.S. and Hamid, Q. (2006) IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J. Allergy Clin. Immunol., 117(3), 590-596.
88. Chakir, J.; Shannon, J.; Molet, S.; Fukakusa, M.; Elias, J.; Laviolette, M.; Boulet, L.P. and Hamid, Q. (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol., 111(6), 1293-1298.
89. Barczyk, A.; Pierzchala, W. and Sozanska, E. (2003) Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med., 97(6), 726-733.
90. Kawaguchi, M.; Onuchic, L.F.; Li, X.D.; Essayan, D.M.; Schroeder, J.; Xiao, H.Q.; Liu, M.C.; Krishnaswamy, G.; Germino, G. and Huang, S.K. (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol., 167(8), 4430-4435.
91. Sergejeva, S.; Ivanov, S.; Lotvall, J. and Linden, A. (2005) Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am. J. Respir. Cell Mol. Biol., 33(3), 248-253.
92. Angkasekwinai, P.; Park, H.; Wang, Y.H.; Chang, S.H.; Corry, D.B.; Liu, Y.J.; Zhu, Z. and Dong, C. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med., 204(7), 1509-1517.
93. Miranda-Carus, M.E.; Benito-Miguel, M.; Balsa, A.; Cobo-Ibanez, T.; Perez de Ayala, C.; Pascual-Salcedo, D. and Martin-Mola, E. (2006) Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum., 54(4), 1151-1164.